These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 25604519)

  • 1. Electrostatic interaction on loading of therapeutic peptide GLP-1 into porous silicon nanoparticles.
    Kaasalainen M; Rytkönen J; Mäkilä E; Närvänen A; Salonen J
    Langmuir; 2015 Feb; 31(5):1722-9. PubMed ID: 25604519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of isotonic solutions and peptide adsorption on zeta potential of porous silicon nanoparticle drug delivery formulations.
    Kaasalainen M; Mäkilä E; Riikonen J; Kovalainen M; Järvinen K; Herzig KH; Lehto VP; Salonen J
    Int J Pharm; 2012 Jul; 431(1-2):230-6. PubMed ID: 22569227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of surface chemistry of porous silicon microparticles on glucagon-like peptide-1 (GLP-1) loading, release and biological activity.
    Huotari A; Xu W; Mönkäre J; Kovalainen M; Herzig KH; Lehto VP; Järvinen K
    Int J Pharm; 2013 Sep; 454(1):67-73. PubMed ID: 23834832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of nanoparticles on the mucosal translocation and transport of GLP-1 across the intestinal epithelium.
    Araújo F; Shrestha N; Shahbazi MA; Fonte P; Mäkilä EM; Salonen JJ; Hirvonen JT; Granja PL; Santos HA; Sarmento B
    Biomaterials; 2014 Nov; 35(33):9199-207. PubMed ID: 25109441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Porous silicon-cell penetrating peptide hybrid nanocarrier for intracellular delivery of oligonucleotides.
    Rytkönen J; Arukuusk P; Xu W; Kurrikoff K; Langel U; Lehto VP; Närvänen A
    Mol Pharm; 2014 Feb; 11(2):382-90. PubMed ID: 24341621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemistry of aqueous silica nanoparticle surfaces and the mechanism of selective peptide adsorption.
    Patwardhan SV; Emami FS; Berry RJ; Jones SE; Naik RR; Deschaume O; Heinz H; Perry CC
    J Am Chem Soc; 2012 Apr; 134(14):6244-56. PubMed ID: 22435500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functionalization of alkyne-terminated thermally hydrocarbonized porous silicon nanoparticles with targeting peptides and antifouling polymers: effect on the human plasma protein adsorption.
    Wang CF; Mäkilä EM; Bonduelle C; Rytkönen J; Raula J; Almeida S; Närvänen A; Salonen JJ; Lecommandoux S; Hirvonen JT; Santos HA
    ACS Appl Mater Interfaces; 2015 Jan; 7(3):2006-15. PubMed ID: 25539741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of a nanocarrier with regulated drug release ability utilizing a reversible conformational transition of a peptide, responsive to slight changes in pH.
    Murai K; Higuchi M; Kinoshita T; Nagata K; Kato K
    Phys Chem Chem Phys; 2013 Jul; 15(27):11454-60. PubMed ID: 23748674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. pH-dependent interaction and resultant structures of silica nanoparticles and lysozyme protein.
    Kumar S; Aswal VK; Callow P
    Langmuir; 2014 Feb; 30(6):1588-98. PubMed ID: 24475981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Confinement and Polarity Effects on the Peptide Packing Density on Mesoporous Silica Nanoparticles.
    Beitzinger B; Schmid R; Jung C; Tiwary K; Hermann P; Jacob T; Lindén M
    Langmuir; 2024 Feb; 40(8):4294-4305. PubMed ID: 38346113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of oxidation level of n(+)-type mesoporous silicon surface on the adsorption and the catalytic activity of Candida rugosa lipase.
    Salis A; Cugia F; Setzu S; Mula G; Monduzzi M
    J Colloid Interface Sci; 2010 May; 345(2):448-53. PubMed ID: 20188377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microfluidic Assembly of a Multifunctional Tailorable Composite System Designed for Site Specific Combined Oral Delivery of Peptide Drugs.
    Araújo F; Shrestha N; Shahbazi MA; Liu D; Herranz-Blanco B; Mäkilä EM; Salonen JJ; Hirvonen JT; Granja PL; Sarmento B; Santos HA
    ACS Nano; 2015 Aug; 9(8):8291-302. PubMed ID: 26235314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous delivery of hydrophobin-functionalized porous silicon nanoparticles: stability, plasma protein adsorption and biodistribution.
    Sarparanta M; Bimbo LM; Rytkönen J; Mäkilä E; Laaksonen TJ; Laaksonen P; Nyman M; Salonen J; Linder MB; Hirvonen J; Santos HA; Airaksinen AJ
    Mol Pharm; 2012 Mar; 9(3):654-63. PubMed ID: 22277076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thermal oxidation for controlling protein interactions with porous silicon.
    Jarvis KL; Barnes TJ; Prestidge CA
    Langmuir; 2010 Sep; 26(17):14316-22. PubMed ID: 20684558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A magnetic, reversible pH-responsive nanogated ensemble based on Fe3O4 nanoparticles-capped mesoporous silica.
    Gan Q; Lu X; Yuan Y; Qian J; Zhou H; Lu X; Shi J; Liu C
    Biomaterials; 2011 Mar; 32(7):1932-42. PubMed ID: 21131045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide adsorption on silica nanoparticles: evidence of hydrophobic interactions.
    Puddu V; Perry CC
    ACS Nano; 2012 Jul; 6(7):6356-63. PubMed ID: 22725630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shape-engineered multifunctional porous silicon nanoparticles by direct imprinting.
    Mares JW; Fain JS; Beavers KR; Duvall CL; Weiss SM
    Nanotechnology; 2015 Jul; 26(27):271001. PubMed ID: 26081802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of Surface Chemistry on Ibuprofen Adsorption and Confinement in Mesoporous Silicon Microparticles.
    Mäkilä E; Kivelä H; Shrestha N; Correia A; Kaasalainen M; Kukk E; Hirvonen J; Santos HA; Salonen J
    Langmuir; 2016 Dec; 32(49):13020-13029. PubMed ID: 27951684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multistage pH-responsive mucoadhesive nanocarriers prepared by aerosol flow reactor technology: A controlled dual protein-drug delivery system.
    Shrestha N; Shahbazi MA; Araújo F; Mäkilä E; Raula J; Kauppinen EI; Salonen J; Sarmento B; Hirvonen J; Santos HA
    Biomaterials; 2015 Nov; 68():9-20. PubMed ID: 26253804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-delivery of a hydrophobic small molecule and a hydrophilic peptide by porous silicon nanoparticles.
    Liu D; Bimbo LM; Mäkilä E; Villanova F; Kaasalainen M; Herranz-Blanco B; Caramella CM; Lehto VP; Salonen J; Herzig KH; Hirvonen J; Santos HA
    J Control Release; 2013 Sep; 170(2):268-78. PubMed ID: 23756152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.